Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
- Thursday, December 12, 2019, 7:03
- Finance
- Add a comment
PRINCETON, N.J., Dec. 12, 2019 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has…
About the Author
adminasapcorp has written 42182 stories on this site.